EFFICACY AND SAFETY OF PATECLIZUMAB (ANTI-LYMPHOTOXIN-ALPHA) IN DMARD-IR PATIENTS: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED HEAD-TO-HEAD PHASE 2 STUDY WITH ADALIMUMAB

被引：0
|
作者：
Kennedy, W. [1 ]
Horn, P. [1 ]
Su, Z. [1 ]
Basu, K. [1 ]
Herman, A. [1 ]
Song, A. [1 ]
Townsend, M. [1 ]
Xiao, J. [1 ]
Grogan, J. [1 ]
Derby, M. [1 ]
Simon-Campos, J. A. [2 ]
Davis, J., Jr. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Ctr Especialidades Med HRAEPY, Merida, Mexico
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：617 / 618
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)
    Kennedy, William P.
    Simon, J. Abraham
    Offutt, Carolyn
    Horn, Priscilla
    Herman, Ann
    Townsend, Michael J.
    Tang, Meina T.
    Grogan, Jane L.
    Hsieh, Frank
    Davis, John C., Jr.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2014, 16 (05)
  • [2] Efficacy and safety of pateclizumab (anti-lymphotoxin-α) compared to adalimumab in rheumatoid arthritis: a head-to-head phase 2 randomized controlled study (The ALTARA Study)
    William P Kennedy
    J Abraham Simon
    Carolyn Offutt
    Priscilla Horn
    Ann Herman
    Michael J Townsend
    Meina T Tang
    Jane L Grogan
    Frank Hsieh
    John C Davis
    [J]. Arthritis Research & Therapy, 16
  • [3] Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
    van der Heijde, Desiree
    Kivitz, Alan
    Schiff, Michael H.
    Sieper, Joachim
    Dijkmans, Ben A. C.
    Braun, Juergen
    Dougados, Maxime
    Reveille, John D.
    Wong, Robert L.
    Kupper, Hartmut
    Davis, John C., Jr.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (07): : 2136 - 2146
  • [4] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [5] Efficacy and safety of oxycodone DETERx: results of a randomized, double-blind, placebo-controlled phase III study
    Kopecky, E.
    O'Connor, M.
    Varanasi, R.
    Saim, S.
    Fleming, A.
    [J]. JOURNAL OF PAIN, 2015, 16 (04): : S87 - S87
  • [6] A randomized double-blind placebo-controlled phase 2 study on the efficacy and safety of fasudil in patients with stable angina
    Vicari, RM
    Chaitman, B
    Keefe, D
    Smith, WB
    Chrysant, ST
    Tonkon, MJ
    Bittar, N
    Weiss, RJ
    Thadani, U
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 254A - 254A
  • [7] A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Talactoferrin in Patients With Severe Sepsis
    Guntupalli, Kalpalatha
    Dean, Nathan
    Morris, Peter E.
    Bandi, Venkata
    Margolis, Benjamin
    Rivers, Emanuel
    Levy, Mitchell
    Lodato, Robert F.
    Ismail, Preeti M.
    Reese, Amber
    Schaumberg, John P.
    Malik, Rajesh
    Dellinger, R. Phillip
    [J]. CRITICAL CARE MEDICINE, 2013, 41 (03) : 706 - 716
  • [8] Efficacy and safety of adalimumab in Chinese patients with moderate to severe plaque psoriasis: Results from a phase 3, randomized, placebo-controlled, double-blind Study
    Zhang, Jianzhong
    Gu, Jun
    Zheng, Jie
    Zheng, Min
    Wang, Gang
    Gu, Yihua
    Okun, Martin
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB232 - AB232
  • [9] GLANCE Results of a phase 2, randomized, double-blind, placebo-controlled study
    Goodman, A. D.
    Rossman, H.
    Bar-Or, A.
    Miller, A.
    Miller, D. H.
    Schmierer, K.
    Lublin, F.
    Khan, O.
    Bormann, N. M.
    Yang, M.
    Panzara, M. A.
    Sandrock, A. W.
    [J]. NEUROLOGY, 2009, 72 (09) : 806 - 812
  • [10] Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study
    Cai, L.
    Gu, J.
    Zheng, J.
    Zheng, M.
    Wang, G.
    Xi, L. -Y.
    Hao, F.
    Liu, X. -M.
    Sun, Q. -N.
    Wang, Y.
    Lai, W.
    Fang, H.
    Tu, Y. -T.
    Sun, Q.
    Chen, J.
    Gao, X. -H.
    Gu, Y.
    Teixeira, H. D.
    Zhang, J. -Z.
    Okun, M. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : 89 - 95
12345